Home » Newsletters » BioWorld Science

BioWorld Science

June 6, 2006

View Archived Issues

BG-00012 safe and reduces brain lesions in relapsing-remitting multiple sclerosis

Gallium maltolate demonstrates effective and safe antibacterial activity in UTI

Lexicon Genetics and BMS extend neuroscience alliance by two years

Neuroprotective effects of NNZ-2556 target delayed cell death

VAS-203 reduces ICP posttraumatic brain injury and improves neurological function

Dosing completed in phase Ib study of AL-208 for neurodegenerative diseases

ICES and MerLion enter antitumor research collaboration

Picoplatin begins phase I/II study in hormone-refractory metastatic prostate cancer

Vion updates pipeline progress

Inspire to file for phase II testing of epinastine for seasonal allergic rhinitis

CytImmune to begin phase I study of CYT-6091 in advanced cancer

Plans for Yondelis filings

Stressgen Biotechnologies changes name to Nventa Biopharmaceuticals

Large outcomes trial planned for Natrecor

Phase III study of glufosfamide recommended to continue to completion

Delay to initiation of phase IIa study of MEM-3454 in Alzheimer's disease

Target enrollment completed in phase IIa study of E1-I.N.T. in type 1 diabetes

Life Science Pharmaceuticals acquires three monoclonal antibody programs

Thelin recommended for approval in Europe

New therapeutic agents for ocular disorders disclosed

Novel treatments for inflammatory disorders reported in recent patents

Patents claim novel therapeutic agents for respiratory disorders

Preliminary phase I/II results suggest MB-07133 warrants further evaluation in HCC

Different administration schedules tested for ZK-304709, an oral multitarget tumor growth inhibitor

Favorable safety, pharmacokinetic and efficacy findings reported for Coramsine

Safety and maximum tolerated dose of imidacrine defined in phase I trials

Phase I/II study reveals good efficacy and safety for TG-1042 in CTCL and CBCL

Intravesical fusion protein associated with excellent tolerability and activity in bladder cancer

New compounds for the treatment of psychiatric disorders reported

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...